Analyzing lung cancer risks in patients with impaired pulmonary function through characterization of gut microbiome and metabolites/Experiment 1/Signature 2

EditHistoryDelete

Mark reviewed

Your review change was submitted

Needs review

Curated date: 2024/03/21

Curator: Omojokunoluwatomisin

Revision editor(s): Omojokunoluwatomisin

Source: figure 2b

Description: Gut microbial composition in lung cancer patients(C) and benign diseases patients(N) Differential taxa at the genus level analyzed by linear discriminant analysis (LDA) scores (LDA > 2.0, P < 0.05).

Abundance in Group 1: decreased abundance in lung cancer

NCBI	Quality Control	Links
Blautia
Subdoligranulum
Lachnoanaerobaculum
Kurthia
Fusicatenibacter
Carnobacterium
unclassified atopobiaceaeunclassified atopobiaceae
Propionibacterium
Coprococcus
Ruminococcus gauvreauii
lachnospiraceae ND 3007lachnospiraceae ND 3007
ruminococcaceae CAG-352ruminococcaceae CAG-352

Revision editor(s): Omojokunoluwatomisin